No insider purchase over the last 90 days. The latest, by Bohjalian Thomas N, was filed 06 Mar 2026.
+2 other insiders
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Healthcare Realty Trust Inc Buy (bullish), based on 12 analysts. Average price target: US$21.08.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
25 of 429 declarations
The two largest purchases at Healthcare Realty Trust Inc date from November 2016 and are David R. Emery's, Chairman/CEO: EUR 1,779,756 on November 9 and EUR 1,417,950 on November 10. John Knox Singleton (Director) bought EUR 495,605 on August 16, 2023. In all, 38 purchases weigh EUR 7.0 million (median EUR 86,207), or 41% of open-market trades, against 55 sales worth EUR 8.4 million (median EUR 100,907). From November 22, 2024 to December 20, 2024, 4 filers bought EUR 471,143. Across the full history, 12 purchase filings are classed as clustered.
The sales are more modest in size: John M. Bryant Jr. (Executive Vice President & GC) EUR 554,910 on May 10, 2018, Amanda L. Callaway (SVP & Chief Accounting Officer) EUR 461,243 on June 23, 2026 and Singleton EUR 429,716 on June 18, 2018.
429 filings from January 4, 2016 to September 9, 2026, 326 of them grants and no option exercise. Yearly volume goes from 26 in 2019 to 63 in 2016. John M. Bryant Jr. is the most frequent filer, with 54 filings, 11 of them sales; Robert E. Hull (EVP and COO) signs 52, Todd J. Meredith (President and CEO) 43. The US real estate company is worth USD 6.23 billion, with 0.6% held by insiders. Last twelve months: 38 filings, 2 purchases, 2 sales. For the 38 purchases with a result, the 90-day median is 1.6%, with 61% of results positive (recorded past, not a forecast).
| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Dec 2025 | 1.18 bn USD | -246.1 m USD | -0.71 USD | 1.10 USD | 10-K |
| Dec 2024 | 1.27 bn USD | -654.5 m USD | -1.81 USD | 1.24 USD | 10-K |
| Dec 2023 | 1.34 bn USD | -278.3 m USD | -0.74 USD | 1.24 USD | 10-K |
| Dec 2022 | 932.6 m USD | 40.9 m USD | 0.15 USD | 1.24 USD | 10-K |
| Dec 2021 | 534.8 m USD | 66.7 m USD | 0.45 USD | 1.21 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.